Segall Bryant & Hamill’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-219,190
| Closed | -$1.15M | – | 849 |
|
|
2018
Q3 | $1.15M | Sell |
219,190
-753,171
| -77% | -$3.96M | 0.02% | 522 |
|
|
2018
Q2 | $5.2M | Sell |
972,361
-28,236
| -3% | -$151K | 0.08% | 282 |
|
|
2018
Q1 | $5M | Buy |
1,000,597
+164,279
| +20% | +$821K | 0.12% | 196 |
|
|
2017
Q4 | $2.76M | Buy |
836,318
+74,307
| +10% | +$245K | 0.06% | 271 |
|
|
2017
Q3 | $2.86M | Sell |
762,011
-19,265
| -2% | -$72.3K | 0.07% | 272 |
|
|
2017
Q2 | $1.99M | Buy |
781,276
+437,043
| +127% | +$1.11M | 0.05% | 306 |
|
|
2017
Q1 | $895K | Sell |
344,233
-25,261
| -7% | -$65.7K | 0.02% | 356 |
|
|
2016
Q4 | $1.13M | Buy |
369,494
+6,925
| +2% | +$21.1K | 0.03% | 342 |
|
|
2016
Q3 | $986K | Buy |
362,569
+25,288
| +7% | +$68.8K | 0.03% | 355 |
|
|
2016
Q2 | $965K | Buy |
+337,281
| New | +$965K | 0.03% | 360 |
|